- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Non-squamous Non-small-cell Lung Cancer
Total 7774 results
-
Qianfoshan HospitalRecruitingAdvanced Non-small Cell Lung CancerChina
-
Bridge Biotherapeutics, Inc.RecruitingEGFR Mutant Advanced Non-Small Cell Lung CancerKorea, Republic of, United States
-
Suzhou Puhe Pharmaceutical Technology Co., LTDNot yet recruitingAdvanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)China
-
TakedaActive, not recruitingAdvanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)United States, Spain, France, Korea, Republic of, Hong Kong, Australia, Taiwan, United Kingdom, Canada, Turkey, Italy, China, Germany, Japan, Austria, Belgium, Greece, Israel, Netherlands, Portugal, Russian Federation, Singapore, Sw... and more
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid Tumors | Non-small Cell Lung CancerUnited States, Italy, Australia, Poland, Spain
-
The Netherlands Cancer InstituteCompletedInoperable Locally Advanced Non Small Cell Lung CancerNetherlands
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedAdvanced or Metastatic Non-Small Cell Lung CancerUnited States, Australia, Brazil, Czech Republic, Russian Federation, Singapore
-
Gustave Roussy, Cancer Campus, Grand ParisNovartisUnknownNon-small Cell Lung Cancer | Locally Advanced DiseaseFrance
-
Hoffmann-La RocheCompleted
-
Guangdong Association of Clinical TrialsUnknownAdvanced Non-squamous NSCLCChina
-
AstraZenecaRecruitingUnresectable /Inoperable Locally Advanced (Stage II-III) Non-small Cells Lung Cancer (NSCLC)Russian Federation
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI)UnknownStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Stage III Non-Small Cell Lung CancerUnited States
-
Xuanzhu Biopharmaceutical Co., Ltd.RecruitingLocally Advanced or Metastatic Solid Tumors | Locally Advanced or Metastatic Non-small Cell Lung CancerChina
-
Karen KellyBristol-Myers Squibb; National Cancer Institute (NCI); TransgeneCompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Stage I Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung CancerUnited States
-
Loma Linda UniversityTerminatedSquamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung CancerUnited States
-
AstraZenecaActive, not recruitingAdvanced Non Small Cell Lung CancerCanada, Poland, Taiwan, United States, Korea, Republic of, Japan, Russian Federation, Ukraine
-
National Cancer Institute, NaplesCompletedAdvanced Non-small Cell Lung CancerItaly
-
Black Diamond Therapeutics, Inc.RecruitingNon-Small Cell Lung Cancer | NSCLC | Metastatic Lung Cancer | Metastatic Lung Non-Small Cell Carcinoma | EGF-R Positive Non-Small Cell Lung Cancer | Advanced Lung Carcinoma | EGFR-TKI Resistant Mutation | Advanced Non-Small Cell Squamous Lung Cancer | Epidermal Growth Factor Receptor C797S | Epidermal...United States
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Not yet recruitingAdvanced Non-small Cell Lung Cancer
-
Achilles Therapeutics UK LimitedTerminatedMelanoma | Advanced Non Small Cell Lung CancerUnited Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Lung Non-Squamous Non-Small Cell CarcinomaUnited States
-
BayerRecruitingAdvanced Solid Tumors | Non-small Cell Lung CancerUnited States, Korea, Republic of, Israel, Japan, China, Australia
-
Dracen Pharmaceuticals, Inc.TerminatedAdvanced Solid Tumor | Non Small Cell Lung Cancer MetastaticUnited States, Taiwan, Germany, Singapore, Spain
-
Betta Pharmaceuticals Co., Ltd.Active, not recruitingAdvanced or Metastatic Non-small Cell LungChina
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Large Cell Lung CancerUnited States
-
Shanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruitingNon-small Cell Lung Cancer | Advanced Lung Carcinoma
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingNSCLC | Lung Cancer | Non-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | PD-L1 Gene Mutation | Non-small Cell Lung Cancer Stage IIIA | Non-small Cell Lung Cancer Stage IIUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)WithdrawnStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Stage IV Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage IIIB | EGFR Negative Non-Small Cell Lung CancerUnited States
-
Zhejiang Genfleet Therapeutics Co., Ltd.RecruitingAdvance Non-small Cell Lung CancerSpain, Italy, Greece
-
J Ints BioRecruitingEGFR Mutant Advanced Non-small Cell Lung CancerKorea, Republic of, United States, Thailand
-
Qianfoshan HospitalRecruitingMetastatic NSCLC | Locally Advanced Non-Small Cell Lung CancerChina
-
Institut BergoniéAstraZenecaRecruitingNon Small Cell Lung Cancer | Advanced Solid TumorFrance
-
Shanghai Junshi Bioscience Co., Ltd.CompletedTreatment-naive Advanced Non-small Cell Lung CancerChina
-
Shanghai JMT-Bio Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownLocally Advanced or Metastatic Non-Small Cell Lung CancerChina
-
Yuankai ShiUnknownAdvanced EGFR-TKI-resistant Non-Small Cell Lung Cancer
-
Millennium Pharmaceuticals, Inc.TerminatedAdvanced Non-Small Cell Lung Cancer | Other Solid Tumors
-
Gene SolutionsRecruitingNon Small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Stage IIIC Non-Small Cell Lung Cancer | Tyrosine Kinase InhibitorsVietnam
-
University of WashingtonNational Cancer Institute (NCI)TerminatedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerSerbia
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); OSI PharmaceuticalsCompletedNon-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung Cancer | Large Cell Lung Cancer | Adenosquamous Cell Lung CancerUnited States
-
Hoffmann-La RocheWithdrawn
-
Genentech, Inc.Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerPoland, Belgium, Spain, United States, Canada, South Africa, Russian Federation, Hong Kong, Taiwan, Japan, France, United Kingdom, Australia, Germany, Hungary, Korea, Republic of, Netherlands, Croatia, Serbia, Israel, Ukraine, Peru, Brazi... and more
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerChina, Korea, Republic of, South Africa, Taiwan, Hungary, France, Netherlands, United States, Bulgaria, Slovakia, Canada, Italy, Brazil, Thailand, Romania, Lithuania, Poland, Latvia, Ukraine, Czech Republic
-
National Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung Cancer | Large Cell Lung Cancer | Adenosquamous Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerCanada
-
BayerNot yet recruitingAdvanced Non-small Cell Lung Cancer | HER2 MutationUnited States, Korea, Republic of, Belgium, China, Japan, Taiwan, Denmark, Germany, Israel, Italy, United Kingdom, Bulgaria, Portugal, Switzerland, Greece, Turkey, Sweden, France, Singapore, Mexico, Spain, Netherlands, Poland, Brazil, A... and more
-
Hubei Cancer HospitalRecruitingNon Small Cell Lung Cancer | Radiotherapy | Immunotherapy | Locally AdvancedChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerChina